Literature DB >> 21589392

Bis[(5-phenyl-1,3,4-thia-diazol-2-yl)sulfan-yl]methane.

He-Wen Wang, Yan Gao, Wei Wang.   

Abstract

The asymmetric unit of the title compound, C(17)H(12)N(4)S(4), contains one half-mol-ecule situated on a twofold rotational axis. In the mol-ecule, the thia-diazole and attached phenyl rings are twisted by 5.8 (3)°.

Entities:  

Year:  2010        PMID: 21589392      PMCID: PMC3011391          DOI: 10.1107/S1600536810044442

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For biological activity of 1,3,4-thia­diazole derivatives, see: Nakagawa et al. (1996 ▶); Wang et al. (1999 ▶); Carvalho et al. (2004 ▶); Riente et al. (2009 ▶); Poorrajab et al. (2009 ▶).

Experimental

Crystal data

C17H12N4S4 M = 400.55 Orthorhombic, a = 10.805 (2) Å b = 19.287 (4) Å c = 4.0738 (8) Å V = 848.9 (3) Å3 Z = 2 Mo Kα radiation μ = 0.57 mm−1 T = 113 K 0.20 × 0.18 × 0.10 mm

Data collection

Rigaku Saturn CCD area-detector diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005 ▶) T min = 0.895, T max = 0.945 6754 measured reflections 1477 independent reflections 1421 reflections with I > 2σ(I) R int = 0.028

Refinement

R[F 2 > 2σ(F 2)] = 0.029 wR(F 2) = 0.124 S = 1.03 1477 reflections 115 parameters H-atom parameters constrained Δρmax = 0.54 e Å−3 Δρmin = −0.55 e Å−3 Absolute structure: Flack (1983 ▶), 554 Friedel pairs Flack parameter: 0.16 (14) Data collection: CrystalClear (Rigaku/MSC, 2005 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810044442/cv2783sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810044442/cv2783Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C17H12N4S4F(000) = 412
Mr = 400.55Dx = 1.567 Mg m3
Orthorhombic, P21212Mo Kα radiation, λ = 0.71073 Å
Hall symbol: P 2 2abCell parameters from 2856 reflections
a = 10.805 (2) Åθ = 2.1–27.9°
b = 19.287 (4) ŵ = 0.57 mm1
c = 4.0738 (8) ÅT = 113 K
V = 848.9 (3) Å3Prism, colourless
Z = 20.20 × 0.18 × 0.10 mm
Rigaku Saturn CCD area-detector diffractometer1477 independent reflections
Radiation source: rotating anode1421 reflections with I > 2σ(I)
confocalRint = 0.028
Detector resolution: 7.31 pixels mm-1θmax = 25.0°, θmin = 2.1°
φ and ω scansh = −12→12
Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005)k = −22→22
Tmin = 0.895, Tmax = 0.945l = −4→4
6754 measured reflections
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH-atom parameters constrained
R[F2 > 2σ(F2)] = 0.029w = 1/[σ2(Fo2) + (0.110P)2] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.124(Δ/σ)max = 0.001
S = 1.02Δρmax = 0.54 e Å3
1477 reflectionsΔρmin = −0.55 e Å3
115 parametersExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
0 restraintsExtinction coefficient: 0.049 (10)
Primary atom site location: structure-invariant direct methodsAbsolute structure: Flack (1983), 554 Friedel pairs
Secondary atom site location: difference Fourier mapFlack parameter: 0.16 (14)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/UeqOcc. (<1)
S10.19317 (6)0.33910 (3)0.3294 (2)0.0215 (3)
S20.13644 (6)0.47579 (4)0.6577 (2)0.0216 (3)
N1−0.0251 (2)0.29797 (13)0.4770 (7)0.0223 (6)
N2−0.0161 (2)0.36481 (13)0.6002 (7)0.0231 (6)
C1−0.0141 (3)0.16581 (16)0.1495 (9)0.0260 (7)
H1−0.09040.17950.24530.031*
C2−0.0048 (3)0.10272 (16)−0.0079 (9)0.0289 (8)
H2−0.07480.0731−0.02060.035*
C30.1073 (3)0.08236 (15)−0.1485 (9)0.0279 (7)
H30.11360.0389−0.25680.033*
C40.2085 (3)0.12546 (15)−0.1299 (9)0.0262 (7)
H40.28470.1117−0.22640.031*
C50.1999 (3)0.18852 (16)0.0284 (8)0.0234 (7)
H50.27040.21780.04200.028*
C60.0885 (3)0.20960 (14)0.1682 (8)0.0196 (6)
C70.0747 (2)0.27771 (15)0.3277 (7)0.0181 (6)
C80.0919 (3)0.39217 (14)0.5395 (8)0.0192 (7)
C90.00000.50000.8888 (11)0.0229 (10)
H9A0.02230.53941.03300.027*0.50
H9B−0.02230.46061.03300.027*0.50
U11U22U33U12U13U23
S10.0163 (4)0.0229 (4)0.0252 (5)−0.0010 (3)0.0012 (4)−0.0011 (3)
S20.0221 (4)0.0204 (4)0.0223 (5)−0.0011 (3)−0.0018 (4)0.0005 (3)
N10.0199 (12)0.0197 (12)0.0273 (14)0.0005 (9)−0.0006 (12)0.0018 (12)
N20.0229 (12)0.0200 (12)0.0263 (15)0.0006 (10)0.0035 (11)−0.0007 (12)
C10.0198 (14)0.0279 (15)0.0303 (18)0.0002 (11)0.0039 (16)0.0029 (17)
C20.0258 (14)0.0254 (15)0.036 (2)−0.0019 (12)−0.0060 (17)−0.0012 (16)
C30.0374 (17)0.0206 (13)0.0257 (17)0.0052 (13)0.0029 (17)−0.0019 (15)
C40.0244 (14)0.0254 (14)0.0289 (18)0.0079 (12)0.0013 (15)0.0031 (16)
C50.0208 (14)0.0232 (14)0.0260 (17)0.0012 (12)−0.0002 (15)0.0041 (14)
C60.0189 (14)0.0209 (14)0.0191 (15)0.0028 (11)−0.0046 (13)0.0043 (14)
C70.0162 (13)0.0216 (13)0.0166 (14)0.0000 (11)−0.0015 (13)0.0033 (13)
C80.0206 (14)0.0198 (12)0.0170 (15)0.0038 (11)−0.0010 (13)−0.0001 (12)
C90.029 (2)0.0235 (19)0.016 (2)−0.0003 (17)0.0000.000
S1—C81.726 (3)C2—H20.9500
S1—C71.744 (3)C3—C41.376 (5)
S2—C81.751 (3)C3—H30.9500
S2—C91.810 (2)C4—C51.380 (5)
N1—C71.298 (4)C4—H40.9500
N1—N21.387 (4)C5—C61.391 (4)
N2—C81.304 (4)C5—H50.9500
C1—C21.379 (5)C6—C71.473 (4)
C1—C61.396 (4)C9—S2i1.810 (2)
C1—H10.9500C9—H9A0.9900
C2—C31.396 (4)C9—H9B0.9900
C8—S1—C786.51 (14)C4—C5—H5119.8
C8—S2—C999.02 (10)C6—C5—H5119.8
C7—N1—N2113.0 (2)C5—C6—C1119.2 (3)
C8—N2—N1111.8 (2)C5—C6—C7121.9 (3)
C2—C1—C6120.1 (3)C1—C6—C7118.9 (3)
C2—C1—H1119.9N1—C7—C6124.0 (3)
C6—C1—H1119.9N1—C7—S1113.8 (2)
C1—C2—C3120.1 (3)C6—C7—S1122.2 (2)
C1—C2—H2119.9N2—C8—S1114.9 (2)
C3—C2—H2119.9N2—C8—S2124.5 (2)
C4—C3—C2119.8 (3)S1—C8—S2120.57 (17)
C4—C3—H3120.1S2—C9—S2i117.3 (2)
C2—C3—H3120.1S2—C9—H9A108.0
C3—C4—C5120.3 (3)S2i—C9—H9A108.0
C3—C4—H4119.9S2—C9—H9B108.0
C5—C4—H4119.9S2i—C9—H9B108.0
C4—C5—C6120.5 (3)H9A—C9—H9B107.2
C7—N1—N2—C8−0.5 (4)C1—C6—C7—N15.7 (5)
C6—C1—C2—C30.1 (5)C5—C6—C7—S14.3 (4)
C1—C2—C3—C40.0 (5)C1—C6—C7—S1−173.9 (3)
C2—C3—C4—C50.3 (6)C8—S1—C7—N1−1.1 (2)
C3—C4—C5—C6−0.6 (5)C8—S1—C7—C6178.6 (3)
C4—C5—C6—C10.7 (5)N1—N2—C8—S1−0.4 (3)
C4—C5—C6—C7−177.6 (3)N1—N2—C8—S2179.9 (2)
C2—C1—C6—C5−0.4 (5)C7—S1—C8—N20.8 (3)
C2—C1—C6—C7177.9 (3)C7—S1—C8—S2−179.5 (2)
N2—N1—C7—C6−178.6 (2)C9—S2—C8—N24.3 (3)
N2—N1—C7—S11.1 (3)C9—S2—C8—S1−175.34 (19)
C5—C6—C7—N1−176.0 (3)C8—S2—C9—S2i−76.74 (11)
  4 in total

1.  Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues.

Authors:  Samir A Carvalho; Edson F da Silva; Ricardo M Santa-Rita; Solange L de Castro; Carlos A M Fraga
Journal:  Bioorg Med Chem Lett       Date:  2004-12-20       Impact factor: 2.823

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Leishmanicidal activity of new megazol derivatives.

Authors:  R R Riente; V P Souza; S A Carvalho; M Kaiser; R Brun; E F da Silva
Journal:  Med Chem       Date:  2009-07       Impact factor: 2.745

4.  Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation.

Authors:  Fatemeh Poorrajab; Sussan Kabudanian Ardestani; Saeed Emami; Mina Behrouzi-Fardmoghadam; Abbas Shafiee; Alireza Foroumadi
Journal:  Eur J Med Chem       Date:  2008-04-09       Impact factor: 6.514

  4 in total
  5 in total

1.  1,4-Bis[(5-phenyl-1,3,4-thia-diazol-2-yl)sulfan-yl]butane.

Authors:  Shao-Feng Li; Jing-Jing Zhang; Xiao-Yu Jia; Yan Gao; Wei Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-23

2.  1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}butane.

Authors:  Qing-Lei Liu; Wei Wang; Yan Gao; Xiao-Yu Jia; Jing-Jing Zhang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-26

3.  2-Methyl-5-[(3-methyl-4-nitro-benz-yl)sulfan-yl]-1,3,4-thia-diazole.

Authors:  Hoong-Kun Fun; Suchada Chantrapromma; B Chandrakantha; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-24

4.  5-[(4-Meth-oxy-benz-yl)sulfan-yl]-2-methyl-1,3,4-thia-diazole.

Authors:  Hoong-Kun Fun; Suchada Chantrapromma; B Chandrakantha; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-18

5.  2-(4-Methyl-phen-yl)-5-[({[5-(4-methyl-phen-yl)-1,3,4-thia-diazol-2-yl]sulfan-yl}meth-yl)sulfan-yl]-1,3,4-thia-diazole.

Authors:  Yong Wang; Wen-Ge Zhang; Yu-Bo Wang; Jing-Wen Yu; Lin Zhou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.